losartan and jd5037
losartan has been researched along with jd5037 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Cinar, R; Earley, BJ; Godlewski, G; Jourdan, T; Ju, C; Kunos, G; Liu, J; Liu, Z; Pacher, P; Rosenberg, AZ; Szanda, G; Tam, J | 1 |
Other Studies
1 other study(ies) available for losartan and jd5037
| Article | Year |
|---|---|
Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.
Topics: Analysis of Variance; Angiotensin II; Animals; Arachidonic Acids; Desmin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Gene Expression Regulation; Losartan; Models, Biological; Podocytes; Pyrazoles; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Receptor, Cannabinoid, CB1; RNA Interference; RNA, Small Interfering; Sulfonamides | 2014 |